Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity
NCT ID: NCT04005417
Last Updated: 2019-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1036 participants
OBSERVATIONAL
2018-01-08
2018-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Meta-analysis of Stannous Fluoride and the Effects on Enamel Erosion
NCT04006470
Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque
NCT04006483
Meta-analysis of Stannous Fluoride and the Effects on Gingival Health
NCT03970759
A Clinical Study to Evaluate a Stannous Fluoride Toothpaste for the Relief of Dentinal Hypersensitivity
NCT03310268
A Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Dentifrice in the Relief of Dentinal Hypersensitivity in a Chinese Population
NCT04950465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stannous fluoride dentifrice
Twice daily brushing
Stannous fluoride dentifrice
Stannous fluoride (0.454%) dentifrice
Positive control dentifrice
Twice daily brushing
Positive control dentifrice
Positive control dentifrice containing potassium nitrate or arginine.
Negative control dentifrice
Twice daily brushing
Negative control dentifrice
Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stannous fluoride dentifrice
Stannous fluoride (0.454%) dentifrice
Positive control dentifrice
Positive control dentifrice containing potassium nitrate or arginine.
Negative control dentifrice
Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* at discretionary of the Principal Investigator
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Procter and Gamble
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Multiple P&G Investigation Clinical Sites
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019SnF2SensitivityAnalysis
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.